Repros Therapeutics Inc.® Reports Third Quarter 2016 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LEN
8. USO
9. LMT
10. META

Go back to Repros Therapeutics Inc.® Reports Third Quarter 2016 Financial Results

Repros Therapeutics (RPRX) Tops Q3 EPS by 1c

November 8, 2016 4:01 PM EST

Repros Therapeutics (NASDAQ: RPRX) reported Q3 EPS of ($0.17), $0.01 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $10 thousand versus the consensus estimate of $1 thousand.

The Company had cash and cash equivalents of approximately $10.5 million as of September 30, 2016 as compared to... More